Zafgen is a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by metabolic diseases including type 2 diabetes and obesity.

Learn More

Our Approach

We're looking at — and targeting — metabolic diseases in a totally different way

Learn More »

Our Science

A steady flow of new scientific evidence continues to reveal insights into the breadth of benefits that can be derived from targeting MetAP2, Zafgen’s focus for new therapeutic development. Learn More »